DAJY(002030)2024-10-30 10:33Financial Performance - The company's operating revenue for Q3 2024 was ¥190,668,689.67, a decrease of 37.71% compared to ¥306,117,783.48 in the same period last year[3]. - The net profit attributable to shareholders was -¥103,500,668.79, representing a decline of 106.34% from -¥50,160,960.00 year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥254,094,958.88, a significant drop of 580.98% compared to -¥74,937,663.66 in the previous year[3]. - The basic earnings per share were -¥0.0737, down 106.44% from -¥0.0357 in the same quarter last year[3]. - The net profit attributable to shareholders of the parent company decreased by 242.58% to -¥502,719,727.25 mainly due to increased credit impairment losses and losses from joint ventures[9]. - The total comprehensive income for the third quarter was -501,375,743.33 CNY, compared to 346,526,377.01 CNY in the previous period[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥9,983,927,839.66, a decrease of 9.38% from ¥11,017,916,882.14 at the end of the previous year[3]. - The equity attributable to shareholders was ¥8,323,762,435.02, down 6.27% from ¥8,880,234,790.09 at the end of the previous year[3]. - The total current assets amounted to ¥5,038,924,096.39, down from ¥5,310,087,998.02, indicating a decrease of about 5.1%[16]. - The total non-current assets decreased to ¥2,733,000,000.00 from ¥2,800,000,000.00, indicating a decline of approximately 2.4%[16]. - Total liabilities decreased to CNY 1,382,151,857.71 from CNY 1,860,849,803.70, reflecting a reduction of 25.7%[18]. - The company's total assets were CNY 9,983,927,839.66, down from CNY 11,017,916,882.14, a decline of 9.4%[19]. - The equity attributable to shareholders of the parent company decreased to CNY 8,323,762,435.02 from CNY 8,880,234,790.09, a drop of 6.3%[19]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥132,419,859.22, a decrease of 53.41% compared to ¥284,229,944.43 in the same period last year[3]. - The net cash flow from investing activities decreased by 139.31% to -¥163,033,122.43 primarily due to a reduction in large time deposits and structured deposit investments[10]. - The net cash flow from financing activities improved by 91.63% to -¥192,031,011.33 due to a decrease in cash dividend distribution compared to the previous year[10]. - Cash inflow from operating activities totaled 1,648,973,451.02 CNY, down from 3,507,663,447.72 CNY in the previous year[23]. - Cash outflow from operating activities was 1,516,553,591.80 CNY, resulting in a net cash flow from operating activities of 132,419,859.22 CNY[23]. - Cash inflow from investment activities was 682,236,243.14 CNY, significantly lower than 2,174,711,968.65 CNY in the previous year[24]. - Cash outflow from investment activities amounted to 845,269,365.57 CNY, leading to a net cash flow from investment activities of -163,033,122.43 CNY[24]. - Cash inflow from financing activities was 138,380,725.05 CNY, compared to 292,869,306.66 CNY in the previous year[24]. - Cash outflow from financing activities reached 330,411,736.38 CNY, resulting in a net cash flow from financing activities of -192,031,011.33 CNY[24]. - The ending balance of cash and cash equivalents was 766,288,486.13 CNY, down from 1,003,945,922.70 CNY in the previous year[24]. Operational Highlights - The company reported a significant increase in fair value changes of financial assets, amounting to ¥186,503,245.95, compared to a loss of -¥105,174,530.56 in the previous year[4]. - The total non-recurring gains and losses amounted to ¥150,594,290.09, contrasting with a loss of -¥69,872,671.51 in the same period last year[5]. - Trading financial assets increased by 78.81% to ¥161,070,991.22 due to an increase in structured deposits[7]. - Prepayments rose by 30.74% to ¥56,205,255.16 primarily due to increased advance payments for procurement by subsidiaries[7]. - Other current assets increased by 33.17% to ¥1,951,644,802.12 mainly due to an increase in time deposits maturing within one year[7]. - Long-term receivables grew by 62.48% to ¥58,347,794.50 as a result of new financing lease projects[7]. - Intangible assets increased by 34.77% to ¥376,945,528.57 due to self-developed intangible assets during the reporting period[7]. - The company obtained multiple medical device registration certificates during the quarter, enhancing its product portfolio[14]. - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development efforts[14]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 155,595, with the largest shareholder holding 16.63% of the shares[11]. - The company reported a significant change in its major shareholders due to securities lending activities, reflecting a dynamic shareholder structure[12]. - The company is actively involved in the securities lending business, with major shareholders participating in this activity[13]. Research and Development - Research and development expenses for Q3 2024 amounted to CNY 167,134,295.16, down 25% from CNY 222,724,481.01 in the previous year[20]. - The company is focusing on cost control and efficiency improvements in response to the declining revenue and profit margins[21]. Audit Status - The report for the third quarter was not audited[25].